Form3, a cloud-native account-to-account platform, announced a new investor: British Patient Capital. Along with existing strategic and financial investors, including Visa, Form3 has now raised a total of $60 million in C-series extension funding to continue its growth journey.
This funding round will enable Form3 to develop new products and services to help support exponential growth in key markets such as the UK, Europe and the US.
This funding announcement follows Visa’s recent investment in Form3 and its cloud-native account-to-account platform. Major strategic players include Visa support and Form3’s vision for the future of next-generation payments infrastructure.
Form3 is the account-to-account platform. Launched in 2016, Form3 set out to revolutionize the world of payment processing and disrupt the traditional payment infrastructure model with an always-on, cloud-native, Payments-as-a-Service platform. And now, Form3 is trusted by some of the UK’s and Europe’s biggest Tier1 banks and fastest-growing fintech to handle their critical payments architecture.
KEY QUOTES:
“British Patient Capital’s investment enables Form3 to continue to deliver mission-critical infrastructure technology for the world’s most established banks and financial institutions.”
-Benyam Hagos, Chief Financial Officer, Form3
“Form3 has built a leading solution for a challenge that banks worldwide are facing: how to transition to a modern, future-proof payments infrastructure. We are delighted to support them as they take the next steps in their growth journey.”
-Tom Haywood, Managing Director, Direct Investments, British Patient Capital
